State Board of Administration of Florida Retirement System’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-18,961
Closed -$1.43M 2314
2022
Q2
$1.43M Sell
18,961
-720
-4% -$32K ﹤0.01% 1109
2022
Q1
$528K Hold
19,681
﹤0.01% 1758
2021
Q4
$939K Buy
19,681
+38
+0.2% +$1.7K ﹤0.01% 1473
2021
Q3
$1.3M Buy
19,643
+510
+3% +$36.3K ﹤0.01% 1275
2021
Q2
$1.49M Buy
19,133
+4,380
+30% +$324K ﹤0.01% 1216
2021
Q1
$1.4M Buy
14,753
+510
+4% +$60.6K ﹤0.01% 1231
2020
Q4
$1.74M Buy
14,243
+2,560
+22% +$280K ﹤0.01% 1135
2020
Q3
$1.02M Buy
11,683
+810
+7% +$56.4K ﹤0.01% 1284
2020
Q2
$702K Buy
10,873
+383
+4% +$22.1K ﹤0.01% 1464
2020
Q1
$468K Buy
10,490
+7,000
+201% +$372K ﹤0.01% 1530
2019
Q4
$217K Buy
+3,490
New +$166K ﹤0.01% 2098

State Board of Administration of Florida Retirement System's TPTX Position: Q3 2022 in Review

State Board of Administration of Florida Retirement System sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 18,961 shares — an estimated $1.43M sold.

State Board of Administration of Florida Retirement System first reported a position in TPTX in Q4 2019 and held it in 11 quarters. The position peaked at $1.74M in Q4 2020. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • State Board of Administration of Florida Retirement System reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • State Board of Administration of Florida Retirement System sold 18,961 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $1.43M.
  • State Board of Administration of Florida Retirement System first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q4 2019 and held it in 11 quarters.
  • State Board of Administration of Florida Retirement System's Turning Point Therapeutics, Inc. Common Stock position peaked at $1.74M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q3 2022, filed 8 Nov 2022.